Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

被引：0
|
作者：
Pia Wegman
Sauli Elingarami
John Carstensen
Olle Stål
Bo Nordenskjöld
Sten Wingren
机构：
[1] Linköping University,Department of Biomedicine and Surgery, Division of Cell Biology, Faculty of Health Sciences
[2] Linköping University,Department of Health and Society, Faculty of Arts and Sciences
[3] Linköping University,Department of Biomedicine and Surgery, Division of Oncology, Faculty of Health Sciences
来源：
Breast Cancer Research | / 9卷
关键词：
Breast Cancer; Tamoxifen; Postmenopausal Patient; Tamoxifen Therapy; Homozygous Carrier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer
    Wegman, Pia
    Elingarami, Sauli
    Carstensen, John
    Stal, Olle
    Nordenskjold, Bo
    Wingren, Sten
    BREAST CANCER RESEARCH, 2007, 9 (01)
  • [2] Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
    Charoenchokthavee, Wanaporn
    Panomvana, Duangchit
    Sriuranpong, Virote
    Areepium, Nutthada
    BREAST CANCER-TARGETS AND THERAPY, 2016, 8 : 149 - 155
  • [3] Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism
    Gjerde, J.
    Hauglid, M.
    Breilid, H.
    Lundgren, S.
    Varhaug, J. E.
    Kisanga, E. R.
    Mellgren, G.
    Steen, V. M.
    Lien, E. A.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 56 - 61
  • [4] The influence of CYP2D6 and CYP3A5 pharmacogenetics on pharmacokinetics of tamoxifen and its metabolites in Asian breast cancer patients
    Chowbay, B.
    Lim, J. S. L.
    Singh, O.
    Ng, R. C. H.
    Wong, N. S.
    Lee, E. J. D.
    EJC SUPPLEMENTS, 2010, 8 (07): : 175 - 175
  • [5] Relationship between Genotypes Sult1a2 and Cyp2d6 and Tamoxifen Metabolism in Breast Cancer Patients
    Fernandez-Santander, Ana
    Gaibar, Maria
    Novillo, Apolonia
    Romero-Lorca, Alicia
    Rubio, Margarita
    Chicharro, Luis Miguel
    Tejerina, Armando
    Bandres, Fernando
    PLOS ONE, 2013, 8 (07):
  • [6] CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR
    Gaedigk, Andrea
    Twist, Greyson P.
    Leeder, J. Steven
    PHARMACOGENOMICS, 2012, 13 (01) : 91 - 111
  • [7] Genetic polymorphisms in CYP1A1, CYP2D6, UGT1A6, UGT1A7, and SULT1A1 genes and correlation with benzene exposure in a Chinese occupational population
    Gu, Shou-Yong
    Zhang, Zhong-Bin
    Wan, Jun-Xiang
    Jin, Xi-Peng
    Xia, Zhao-Lin
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2007, 70 (11-12): : 916 - 924
  • [8] Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters
    Brauch, Hiltrud
    Schroth, Werner
    Goetz, Matthew P.
    Muerdter, Thomas E.
    Winter, Stefan
    Ingle, James N.
    Schwab, Matthias
    Eichelbaum, Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) : 176 - 180
  • [9] Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients
    Lim, Joanne S. L.
    Chen, Xiang A.
    Singh, Onkar
    Yap, Yoon S.
    Ng, Raymond C. H.
    Wong, Nan S.
    Wong, Mabel
    Lee, Edmund J. D.
    Chowbay, Balram
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (05) : 737 - 750
  • [10] Relationship between CYP2D6 and SULT1A1 genotypes and serum concentrations of tamoxifen and its metabolites during steady state treatment in breast cancer patients
    Gjerde, J
    Hauglid, M
    Breilid, H
    Lundgren, S
    Varhaug, JE
    Kisanga, ER
    Mellgren, G
    Steen, VM
    Lien, EA
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S236 - S237
12345